Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

NASDAQ:PHLT - US71377E1055 - Common Stock

7.6 USD
+0.01 (+0.13%)
Last: 8/26/2025, 8:00:01 PM
7.6 USD
0 (0%)
After Hours: 8/26/2025, 8:00:01 PM
Fundamental Rating

3

Overall PHLT gets a fundamental rating of 3 out of 10. We evaluated PHLT against 101 industry peers in the Health Care Providers & Services industry. The financial health of PHLT is average, but there are quite some concerns on its profitability. PHLT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PHLT had negative earnings in the past year.
In the past year PHLT had a positive cash flow from operations.
In the past 5 years PHLT always reported negative net income.
PHLT had a positive operating cash flow in 4 of the past 5 years.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.80%, PHLT is in line with its industry, outperforming 44.55% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.08%, PHLT is in line with its industry, outperforming 52.48% of the companies in the same industry.
The Return On Invested Capital of PHLT (0.19%) is worse than 61.39% of its industry peers.
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROIC 0.19%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Operating Margin of PHLT (0.16%) is worse than 61.39% of its industry peers.
The Profit Margin and Gross Margin are not available for PHLT so they could not be analyzed.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHLT is destroying value.
Compared to 1 year ago, PHLT has more shares outstanding
The number of shares outstanding for PHLT has been increased compared to 5 years ago.
The debt/assets ratio for PHLT is higher compared to a year ago.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 13.18 indicates that PHLT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.18, PHLT belongs to the top of the industry, outperforming 96.04% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that PHLT is not too dependend on debt financing.
PHLT has a Debt to Equity ratio of 0.10. This is in the better half of the industry: PHLT outperforms 76.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 13.18
ROIC/WACC0.02
WACC8.91%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.64 indicates that PHLT has no problem at all paying its short term obligations.
PHLT's Current ratio of 2.64 is amongst the best of the industry. PHLT outperforms 82.18% of its industry peers.
PHLT has a Quick Ratio of 2.64. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PHLT (2.64) is better than 82.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.50% over the past year.
The Revenue has grown by 15.21% in the past year. This is quite good.
PHLT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.95% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%

3.2 Future

Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 59.27% on average per year.
PHLT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.37% yearly.
EPS Next Y89.54%
EPS Next 2Y66.87%
EPS Next 3Y59.27%
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 74.51, the valuation of PHLT can be described as expensive.
PHLT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, PHLT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 74.51
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

62.38% of the companies in the same industry are cheaper than PHLT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 93.32
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHLT's earnings are expected to grow with 59.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.87%
EPS Next 3Y59.27%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (8/26/2025, 8:00:01 PM)

After market: 7.6 0 (0%)

7.6

+0.01 (+0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners78.74%
Inst Owner ChangeN/A
Ins Owners4.52%
Ins Owner Change4.72%
Market Cap600.40M
Analysts82
Price Target7.91 (4.08%)
Short Float %1.27%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.22%
Min EPS beat(2)100%
Max EPS beat(2)276.44%
EPS beat(4)4
Avg EPS beat(4)104.9%
Min EPS beat(4)1.96%
Max EPS beat(4)276.44%
EPS beat(8)8
Avg EPS beat(8)102.34%
EPS beat(12)11
Avg EPS beat(12)79.64%
EPS beat(16)14
Avg EPS beat(16)64.19%
Revenue beat(2)2
Avg Revenue beat(2)10.95%
Min Revenue beat(2)9%
Max Revenue beat(2)12.91%
Revenue beat(4)2
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)12.91%
Revenue beat(8)6
Avg Revenue beat(8)3.99%
Revenue beat(12)7
Avg Revenue beat(12)1.42%
Revenue beat(16)10
Avg Revenue beat(16)2.44%
PT rev (1m)6.9%
PT rev (3m)10.71%
EPS NQ rev (1m)-200.3%
EPS NQ rev (3m)-49.92%
EPS NY rev (1m)-188.87%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)1.25%
Revenue NY rev (3m)1.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 74.51
P/S 4.37
P/FCF N/A
P/OCF 124.93
P/B 7.3
P/tB 17.22
EV/EBITDA 93.32
EPS(TTM)-0.01
EYN/A
EPS(NY)0.1
Fwd EY1.34%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.06
OCFY0.8%
SpS1.74
BVpS1.04
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROCE 0.24%
ROIC 0.19%
ROICexc 0.21%
ROICexgc 0.48%
OM 0.16%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.25
Cap/Depr 84.63%
Cap/Sales 3.82%
Interest Coverage 0.27
Cash Conversion 74.84%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 13.18
F-Score6
WACC8.91%
ROIC/WACC0.02
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y89.54%
EPS Next 2Y66.87%
EPS Next 3Y59.27%
EPS Next 5YN/A
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y104.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.69%
EBIT Next 3Y72.41%
EBIT Next 5YN/A
FCF growth 1Y-183.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.31%
OCF growth 3Y88.66%
OCF growth 5YN/A